reference/35192148

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35192148

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2052-4897
issueIdentifier	5
pageRange	e003036-
publicationName	BMJ Open Diabetes Research & Care
startingPage	e003036
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3acf6fd6f55cd99d24ef0408346b7c3a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_26d980d8775f426e26b7b88ff1d3e450 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8987b70eb6dac679c39bccdadad8398d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f6572fb13d20982be200e53ce9858b72
bibliographicCitation	Newby D, Linden AB, Fernandes M, Molero Y, Winchester L, Sproviero W, Ghose U, Li QS, Launer LJ, Duijn CMV, Nevado-Holgado AJ. Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus. BMJ Open Diab Res Care. 2022 Sep;10(5):e003036. doi: 10.1136/bmjdrc-2022-003036.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a08ace2972c7d747d8cd5c2ca76545c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f9fc478963d2f0c3aab77ac0568e273 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08360270cfcc914ea1e770e5c4935928 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d54941959644376672148353eb6f9eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38b4e78c0099385a94c492105c2abad3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d901b7406217530b0d6cddfd79981f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbcafa7d86838e4371e34c49f9413843 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8310bdaef8d8d56a9333bbef08537a72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bcfa1041b3bdc72d0b525b08ed5e33a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_231d625e28018369bf9e57ec0a573bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3001-1478
date	202209
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9478804 https://pubmed.ncbi.nlm.nih.gov/36109050 https://doi.org/10.1136/bmjdrc-2022-003036
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43158 https://portal.issn.org/resource/ISSN/2052-4897
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus
discusses	http://id.nlm.nih.gov/mesh/M0013535 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0020795
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003924Q000150 http://id.nlm.nih.gov/mesh/D010300Q000150 http://id.nlm.nih.gov/mesh/D003704Q000209 http://id.nlm.nih.gov/mesh/D010300Q000453 http://id.nlm.nih.gov/mesh/D008687Q000009 http://id.nlm.nih.gov/mesh/D003924Q000453 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D003704Q000453 http://id.nlm.nih.gov/mesh/D010300Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013453Q000009 http://id.nlm.nih.gov/mesh/D007004Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9662 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104818 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Showing number of triples: 1 to 60 of 60.